Newsflow expected this quarter :
- Bioequivalence Trial scheduled to commence first QTR 2024 (~FEB)
- The trial only takes 5 days.
- First patient enrolments
- First patient dosing
- Last patient dosing
- Trial results – say 30 days post
- They then plan for first sales under special access in Australia in 2nd QTR 2024 (based on trial results), and move immediately to apply registration with the FDA (US).
- Forums
- ASX - By Stock
- LTP
- Ann: LTR Pharma to List on the ASX
Ann: LTR Pharma to List on the ASX, page-127
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTP (ASX) to my watchlist
|
|||||
Last
83.0¢ |
Change
0.020(2.47%) |
Mkt cap ! $58.43M |
Open | High | Low | Value | Volume |
84.5¢ | 84.5¢ | 82.5¢ | $53.47K | 63.95K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 21849 | 82.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
85.0¢ | 14469 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 9136 | 0.830 |
4 | 26393 | 0.825 |
2 | 3343 | 0.820 |
3 | 61649 | 0.815 |
3 | 103967 | 0.810 |
Price($) | Vol. | No. |
---|---|---|
0.850 | 7109 | 2 |
0.860 | 12645 | 2 |
0.865 | 10346 | 2 |
0.870 | 20000 | 1 |
0.875 | 15000 | 1 |
Last trade - 10.46am 11/07/2024 (20 minute delay) ? |
Featured News
LTP (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online